Relationship between Dose Prescription Methods and Local Control Rate in Stereotactic Body Radiotherapy for Early Stage Non-Small-Cell Lung Cancer: Systematic Review and Meta-Analysis
Applying Artificial Neural Networks to Develop a Decision Support Tool for Tis-4N0M0 Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy
Impact of Local Recurrence on Cause-Specific Death After Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Dynamic Prediction Using Landmark Model
Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4–B1: a pilot study
Development and validation of a prognostic model for non-lung cancer death in elderly patients treated with stereotactic body radiotherapy for non-small cell lung cancer
Comparison of stereotactic body radiotherapy and radiofrequency ablation for hepatocellular carcinoma: Systematic review and meta‐analysis of propensity score studies
Stereotactic Body Radiation Therapy With a High Maximum Dose Improves Local Control, Cancer-Specific Death, and Overall Survival in Peripheral Early-Stage Non-Small Cell Lung Cancer
Safety and efficacy study: Short-term application of radiofrequency ablation and stereotactic body radiotherapy for Barcelona Clinical Liver Cancer stage 0-B1 hepatocellular carcinoma
Simple low-cost approaches to semantic segmentation in radiation therapy planning for prostate cancer using deep learning with non-contrast planning CT images
Clinical impact of radiofrequency ablation and stereotactic body radiation therapy for colorectal liver metastasis as local thrapies for elderly, vulnerable patients
Methodological Concerns for Investigating the Effects of Mid-Treatment Break of Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma (HCC)
Stereotactic body radiotherapy for primary non-small cell lung cancer patients with clinical T3-4N0M0 (UICC 8th edition): outcomes and patterns of failure
Narita A, Takeda A, Eriguchi T, Saigusa Y, Sanuki N, Tsurugai Y, Enomoto T, Kuribayashi H, Mizuno T, Yashiro K, Hara Y, Kaneko T.
J Radiat Res. 2019 Oct 23;60(5):639-649.
Substantial imbalance that is never eliminated with propensity score matched analyses in comparing surgery to stereotactic body radiotherapy for patients with early-stage non-small cell lung cancer
Takeda A, Tsurugai Y, Sanuki N.
J Thorac Dis. 2019 May;11(Suppl 9):S1415-S1419.
Stereotactic body radiotherapy for patients with non-small-cell lung cancer using RapidArc delivery and a steep dose gradient: prescription of 60% isodose line of maximum dose fitting to the planning target volume
Tsurugai Y, Takeda A, Sanuki N, Eriguchi T, Aoki Y, Oku Y, Akiba T, Sugawara A, Kunieda E.
J Radiat Res. 2019 May 1;60(3):364-370.
Pleural contact decreases survival in clinical T1N0M0 lung cancer patients undergoing SBRT
Stereotactic Body Radiation Therapy for Patients with Pulmonary Interstitial Change: High Incidence of Fatal Radiation Pneumonitis in a Retrospective Multi-Institutional Study
Onishi H, Yamashita H, Shioyama Y, Matsumoto Y, Takayama K, Matsuo Y, Miyakawa A, Matsushita H, Aoki M, Nihei K, Kimura T, Ishiyama H, Murakami N, Nakata K, Takeda A, Uno T, Nomiya T, Takanaka T, Seo Y, Komiyama T, Marino K, Aoki S, Saito R, Araya M, Maehata Y, Tominaga L, Kuriyama K.
Cancers (Basel). 2018 Aug 2;10(8):257.
Are Head-to-Head Comparisons Between Radiofrequency Ablation and Stereotactic Body Radiotherapy Really Necessary for Localized Hepatocellular Carcinoma?
Sanuki N, Takeda A.
J Clin Oncol. 2018 Aug 20;36(24):2563-2564.
Clarithromycin mitigates radiation pneumonitis in patients with lung cancer treated with stereotactic body radiotherapy
Takeda A, Tsurugai Y, Sanuki N, Enomoto T, Shinkai M, Mizuno T, Aoki Y, Oku Y, Akiba T, Hara Y,Kunieda E.
J Thorac Dis. 2018 Jan;10(1):247-261
Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database
Shioyama Y, Onishi H, Takayama K, Matsuo Y, Takeda A, Yamashita H, Miyakawa A, Murakami N, Aoki M, Matsushita H, Matsumoto Y, Shibamoto Y; Japanese Radiological Society Multi-Institutional SBRT Study Group (JRS-SBRTSG).
Technol Cancer Res Treat. 2018 Jan 1:17:1533033818783904
Stereotactic body radiotherapy for lung cancer patients with idiopathic interstitial pneumonias
Tsurugai Y, Takeda A, Sanuki N, Enomoto T, Kaneko T, Hara Y, Mizuno T, Saeki N, Aoki Y, Oku Y, Akiba T, Kunieda E.
Radiother Oncol. 2017 Nov;125(2):310-316
Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer
Eriguchi T, Takeda A, Sanuki N, Tsurugai Y, Aoki Y, Oku Y, Hara Y, Akiba T, Shigematsu N.
Lung Cancer. 2017 Jul:109:62-67
＜2016年＞
Phase II study of stereotactic body radiotherapy and optional trans-arterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation
Takeda A, Sanuki N, Tsurugai Y, Iwabuchi S, Matsunaga K, Ebinuma H, Imajo K, Aoki Y, Saito H, Kunieda E
Cancer. 2016 Jul 1;122(13):2041-9.
放射線有害反応と対策８ 放射線治療における注意事項 ―ペースメーカーと植え込み型除細動器―
佐貫直子，鶴貝雄一郎，武田篤也
乳癌の臨床 2016; 31(1), p37-42
Relationship between the consolidation to maximum tumor diameter ratio and outcomes following stereotactic body radiotherapy for stage I non-small-cell lung cancer
Tsurugai Y, Kozuka T, Ishizuka N, Oguchi M.
Lung Cancer. 2016 Feb;92:47-52
Stereotactic body radiotherapy for chronic obstructive pulmonary disease patients undergoing or eligible for long-term domiciliary oxygen therapy
Hara Y, Takeda A, Eriguchi T, Sanuki N, Aoki Y, Nishimura S, Enomoto T, Shinkai M, Kawana A, Kaneko T.
J Radiat Res. 2016 Jan;57(1):62-7
Stereotactic body radiotherapy (SBRT) for T3 and T4N0M0 non-small cell lung cancer
Eriguchi T, Takeda A, Sanuki N, Nishimura S, Takagawa Y, Enomoto T, Saeki N, Yashiro K, Mizuno T, Aoki Y, Oku Y, Yokosuka T, Shigematsu N
J Radiat Res. 2016 Jun;57(3):265-72
Stereotactic Body Radiotherapy for Patients with Oligometastases from Colorectal Cancer: Risk-adapted Dose Prescription with a Maximum Dose of 83-100 Gy in 5 Fractions
Takeda A, Sanuki N, Tsurugai Y,Oku Y, Aoki Y
J Radiat Res. 2016 Jul;57(4):400-5
＜2015年＞
Dose-Escalated Stereotactic Body Radiotherapy (SBRT) as a Salvage Treatment for Two Cases with Relapsed Peripheral Lung Cancer After Initial SBRT
Nishimura S, Takeda A, Sanuki N, Yoshida S, Shigematsu N.
J Thorac Oncol. 2015 Aug;10(8):e69-71
Influence of liver toxicities on prognosis after stereotactic body radiation therapy for hepatocellular carcinoma
Sanuki N, Takeda A, Oku Y, Eriguchi T, Nishimura S, Aoki Y, Kunieda E.
Hepatol Res. 2015 May;45(5):540-7.
Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume
Takeda A, Oku Y, Sanuki N, Eriguchi T, Aoki T, Enomoto T, Kaneko T, Nishimura S, Kunieda E
J Radiat Res. 2014 Sep;55(5):988-95.
Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors
Nishimura S, Takeda A, Sanuki N, Ishikura S, Oku Y, Aoki Y, Kunieda E, Shigematsu N.
J Thorac Oncol. 2014 Sep;9(9):1370-6.
Subclinical interstitial lung disease: Is it a risk factor for fatal radiation pneumonitis following stereotactic body radiotherapy?
Takeda A, Sanuki N, Enomoto T, Kunieda E.
Lung Cancer. 2014; 83(1):112
Stereotactic body radiotherapy for small hepatocellular carcinoma: A retrospective outcome analysis in 185 patients
Sanuki N, Takeda A, Oku Y, Mizuno T, Aoki Y, Eriguchi T, Iwabuchi S, Kunieda E
Acta Oncol. 2014 Mar;53(3):399-404.
The Japanese Breast Cancer Society clinical practice guideline for radiotherapy of breast cancer
Sekiguchi K, Ogawa Y, Sanuki N, Arahira S, OgoE, Yoshimura M, Yamauchi C, Oguchi M, Ohsumi S, Mukai H
Breast Cancer. 2014 Jul 15. [Epub ahead of print]
Stereotactic ablative radiotherapy for small hepatocellulacr carcinoima: outcomes in 185 patients
Sanuki N, Takeda A, Oku Y, Mizuno T, Aoki Y, Eriguchi T, Iwabuchi S, Kunieda E
Acta Oncol 2014; 53(3): 399-404
Threshold Doses for Focal Liver Reaction After Stereotactic Ablative Body Radiation Therapy for Small Hepatocellular Carcinoma Depend on Liver Function: Evaluation on Magnetic Resonance Imaging With Gd-EOB-DTPA
Sanuki N, Takeda A, Oku Y, Eriguchi T, Nishimura S, Aoki S, Mizuno T, Iwabuchi S, and Kunieda E
Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):306-11
Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma
Takeda A, Sanuki N, Eriguchi T, Kobayashi T, Iwabutchi S, Matsunaga K, Mizuno T, Yashiro K, Nisimura S, Kunieda E
J Gastroenterol Hepatol. 2014 Feb;29(2):372-9
Stereotactic Ablative Body Radiotherapy with Dynamic Conformal Multiple Arc Therapy for Liver Tumors: Optimal Isodose Line Fitting to the Planning Target Volume
Oku Y, Takeda A, Sanuki N, Sudo Y, Oooka Y, Aoki Y, Shimouchi Y , Nishina R, Nomura K, Eriguchi T, Kunieda E
Pract Radiat Oncol. 2014 Jan-Feb;4(1):e7-e13
The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of overall and disease-free survival for non-small-cell lung cancer patients following stereotactic body radiotherapy (SBRT)
Takeda A, Sanuki N, Fujii H, Yokosuka N, Nishimura S, Aoki Y, Oku Y, Ozawa Y, Kunieda E
J Thorac Oncol 2013; 2014 Jan;9(1):65-73
＜2013年＞
Tumor response on CT following hypofractionated stereotactic ablative body radiotherapy for small hypervascular hepatocellular carcinoma with cirrhosis
Sanuki N, Takeda A, Mizuno T, Oku Y, Eriguchi T, Iwabuchi S, Kunieda E
AJR Am J Roentgenol. 2013 Dec;201(6):W812-20.
Salvage Stereotactic Ablative Irradiation for Isolated Postsurgical Local Recurrence of Lung Cancer
Takeda A, Sanuki N, Eriguchi T, Enomoto T, Yokosuka T, Kaneko T, Handa H, Aoki Y, Oku Y, Kunieda E
Ann Thorac Surg 2013: 2013 Nov;96(5):1776-82
Axillary Irradiation with High Tangent Fields for Clinically Node-negative Breast Cancer: Can 3-Dimensional Conformal Radiotherapy with a Field-in-field Technique Better Control the Axilla?
Sanuki N, Takeda A, Amemiya A, Ofuchi T, Ono M, Ogata H, Yamagami R, Hatayama J, Eriguchi T, Kunieda E
Breast Care (Basel). 2013 Oct;8(5):362-7.
A case of recurrent non-small cell lung cancer successfully treated with multiple modality therapies including S-1 monotherapy as fifth-line chemotherapy hospital
Yokosuka T, Kobayashi T, Enomoto T, Takeda A
Gan To Kagaku Ryoho. 2013 Sep;40(9):1201-3.
Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system
Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma – benchmark for a prospective multi-institutional study
Eriguchi T, Takeda A, Oku Y, Ishikura S, Kimura T, Ozawa S, Nakashima T, Matsuo Y, Nakamura M, Matsumoto Y, Yamazaki S, Sanuki N, Ito Y
Radiat Oncol. 2013 May 4:8:113.
Evaluation for local failure by CT and 18F-FDG PET/CT at one year after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer
Takeda A, Kunieda E, Fujii H, Yokosuka N, Aoki Y, Oooka Y, Oku Y, Ohashi T, Sanuki N, Mizuno T, Ozawa Y.
Lung Cancer. 2013 Mar;79(3):248-53.
Stereotactic ablative body radiotherapy (SABR) for octogenarians with non-small cell cancer
Takeda A, Sanuki N, Eriguchi T, Kaneko T, Morita S, Handa H, Aoki Y, Oku Y, Kunieda E
Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):257-63
肝細胞癌に対するSBRTのピットフォール
佐貫直子，武田篤也，奥洋平，江里口貴久，国枝悦夫
臨床放射線 58:682-690, 2013
PMRT 用語解説
佐貫直子，武田篤也
Cancer Board乳癌 Vol.6:No.1, p.96-97, 2013
Evaluation of microscopic tumor extension in early-stage cervical cancer: quantifying subclinical uncertainties by pathological and magnetic resonance imaging findings
Sanuki N, Urabe S, Matsumoto H, Ono A, Komatsu E, Kamei N, Maeda T
J Radiat Res 2013; 54(4):719-26
術後断端再発例への救済的体幹部定位放射線治療
武田篤也，江里口貴久，佐貫直子
日本臨床 2013; 71 (supple 6): 662-666
Threshold Doses for Focal Liver Reaction Following Stereotactic Ablative Body Radiotherapy for Small Hepatocellular Carcinoma Depend on Liver Function: Evaluation on Magnetic Resonance Imaging with Gd-EOB-DTPA
Sanuki N, Takeda A, Oku Y, Mizuno T, Aoki Y, Eriguchi T, Nishimura S, Iwabuchi S, Kunieda E
Int J Radiat Oncol Biol Phys. 2014; 88(2):306-11
Locally advanced granulocyte colony-stimulating factor-producing non-small cell lung cancer successfully treated with concurrent chemoradiotherapy
Yokosuka T, Enomoto T, Takeda A, Kobayashi T.
Gan To Kagaku Ryoho. 2013 Nov;40(12):2330-2.
Outcomes of Clinically Node-Negative Breast Cancer Without Axillary Dissection: Can Preserved Axilla Be Safely Treated With Radiation After a Positive Sentinel Node Biopsy?
Reassessment of declines in pulmonary function ≥1 year after stereotactic body radiotherapy
Takeda A, Kunieda E, Sanuki N, Aoki Y, Oku Y, Handa H.
Chest. 2013 Jan;143(1):130-137.
＜2012年＞
Multiple myeloma relapse in the irradiated liver: involvement of hepatocyte growth factor akin to that after hepatocyte transplantation
Uetake A, Takeda A, Shigematsu N, Ikeda E, Kametaka M, Kunieda E, Ohashi T.
Journal of Radiotherapy in Practice 2012;11:271-3
Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours
Takeda A, Ohashi T, Kunieda E, Sanuki N, Enomoto T, Takeda T, Oku Y, Shigematsu N.
Br J Radiol. 2012 May;85(1013):636-42.
Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy
Takeda A, Kunieda E, Ohashi T, Aoki Y, Oku Y, Enomoto T, Nomura K, Sugiura M.
Chest. 2012 ;141(4):858-66.
Dose volume histogram analysis of focal liver reaction in follow-up multiphasic CT following stereotactic body radiotherapy for small hepatocellular carcinoma
Takeda A, Oku Y, Sanuki N, Kunieda E, Koike N, Aoki Y, Ohashi T, Iwabuchi S, Takatsuka K, Takeda T, Sugawara A.
Radiother Oncol. 2012;104(3):374-8
Acute exacerbation of usual interstitial pneumonia after resection of lung cancer
Sugiura H, Takeda A, Hoshi T, Kawabata Y, Sayama K, Jinzaki M, Kuribayashi S.
Ann Thorac Surg. 2012 Mar;93(3):937-43.
Preimplant factors affecting prostate D90 after transperineal interstitial prostate brachytherapy with loose 125I seeds
Akitomo Sugawara, Jun Nakashima, Etsuo Kunieda, Hirohiko Nagata, Ryuichi Mizuno, Atsuya Takeda, Satoshi Seki, Yutaka Shiraishi, Ryuichi Kouta, Mototsugu Oya, Naoyuki Shigematsu
2012 Keio Journal of Medicine 61(3), pp.89-94.
肝細胞癌に対する体幹部定位放射線治療 体幹部定位放射線治療の効果と位置づけ
武田篤也，佐貫直子，江里口貴久
Liver Cancer Journal. 2012 ; 4(4): 43-48
Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: Comparison with non-small-cell lung cancer
Takeda A, Kunieda E, Sanuki N, Aoki Y, Oku Y, Handa H.
Lung Cancer. 2012;77(1):77-82
＜2011年＞
Stereotactic Body Radiotherapy (SBRT) for Operable Stage I Non-Small-Cell Lung Cancer: Can SBRT Be Comparable to Surgery?
Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Karasawa K, Hayakawa K, Niibe Y, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Kozuka T, Arimoto T, Hara R, Itami J, Araki T.
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1352-8.
The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SBRT)
Takeda A, Yokosuka N, Ohashi T, Kunieda E, Fujii H, Aoki Y, Sanuki N, Koike N, Ozawa Y.
Radiother Oncol. 2011 Nov;101(2):291-7.
Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer
Takeda A, Kunieda E, Ohashi T, Aoki Y, Koike N, Takeda T.
Radiother Oncol. 2011 Nov;101(2):255-9.
Radiotherapy quality assurance review for a multi-center randomized trial of locally advanced esophageal cancer: the Japan Clinical Oncology Group (JCOG) trial 0303
Sanuki N, Ishikura S, Shinoda M, Ito Y, Hayakawa K, Ando N.
Int J Clin Oncol. 2011 Jun 14.
Analysis of suitable prescribed isodose line fitting to planning target volume in stereotactic body radiotherapy using dynamic conformal multiple arc therapy
Oku Y, Takeda A, Kunieda E, Sudo Y, Oooka Y, Aoki Y, Shimouchi Y, Nishina R, Nomura K, Sugiura M, Ohashi T.
Practical Radiation Oncol 2011;2(1):46-53
＜2010年＞
CT evaluations of focal liver reactions following stereotactic body radiotherapy for small hepatocellular carcinoma with cirrhosis: relationship between imaging appearance and baseline liver function
Sanuki-Fujimoto N, Takeda A, Ohashi T, Kunieda E, Iwabuchi S, Takatsuka K, Koike N, Shigematsu N.
Br J Radiol. 2010 Dec;83(996):1063-71.
Weekly Low-Dose Docetaxel-Based Chemoradiotherapy for Locally Advanced Oropharyngeal or Hypopharyngeal Carcinoma: A Retrospective, Single-Institution Study
Fukada J, Shigematsu N, Takeda A, Ohashi T, Tomita T, Shiotani A, Kunieda E, Kawaguchi O, Fujii M, Kubo A.
Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):417-24
Early graphical appearance of radiation pneumonitis correlates with the severity of radiation pneumonitis after stereotactic body radiotherapy (SBRT) in patients with lung tumors
Takeda A, Ohashi T, Kunieda E, Enomoto T, Sanuki N, Takeda T, Shigematsu N.
Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):685-90.
＜2009年＞
Clinical Outcomes of Stereotactic Body Radiotherapy for Small Lung Lesions Clinically Diagnosed as Primary Lung Cancer on Radiologic Examination
Inoue T, Shimizu S, Onimaru R, Takeda A, Onishi H, Nagata Y, Kimura T, Karasawa K, Arimoto T, Hareyama M, Kikuchi E, Shirato H.
Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):683-7.
The reproducibility of a HeadFix relocatable fixation system: analysis using the stereotactic coordinates of bilateral incus and the top of the crista galli obtained from a serial CT scan
Kunieda E, Oku Y, Fukada J, Kawaguchi O, Shiba H, Takeda A, Kubo A.
Phys Med Biol. 2009 May 21;54(10):N197-204.
Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202
Sanuki-Fujimoto N, Ishikura S, Hayakawa K, Kubota K, Nishiwaki Y, Tamura T.
Radiat Oncol. 2009 Jun 2;4:16.
Stereotactic radiosurgery with an upper partial denture
Tayama S, Kunieda E, Oku Y, Takeda A, Takeda T.
Keio J Med. 2009 Jun;58(2):120-3.
Relation between elective nodal failure and irradiated volume in non-small-cell lung cancer (NSCLC) treated with radiotherapy using conventional fields and doses.
Sanuki-Fujimoto N, Sumi M, Ito Y, Imai A, Kagami Y, Sekine I, Kunitoh H, Ohe Y, Tamura T, Ikeda H.
Radiother Oncol. 2009 Jun;91(3):433-7.
Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm
Takeda A, Sanuki N, Kunieda E, Ohashi T, Oku Y, Takeda T, Shigematsu N, Kubo A.
Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):442-8.
Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapy
Takeda A, Kunieda E, Sanuki N, Ohashi T, Oku Y, Sudo Y, Iwashita H, Ooka Y, Aoki Y, Shigematsu N, Kubo A.
Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):363-9.
Dose distribution analysis of axillary lymph nodes for three-dimensional conformal radiotherapy with a field-in-field technique for breast cancer
Ohashi T, Takeda A, Shigematsu N, Fukada J, Sanuki N, Amemiya A, Kubo A.
Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):80-7.
Extrapulmonary soft-tissue fibrosis resulting from hypofractionated stereotactic body radiotherapy for pulmonary nodular lesions
Kawase T, Takeda A, Kunieda E, Kokubo M, Kamikubo Y, Ishibashi R, Nagaoka T, Shigematsu N, Kubo A.
Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):349-54.
＜2008年＞
Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing
Takeda A, Enomoto T, Sanuki N, Nakajima T, Takeda T, Sayama K, Kunieda E.
Radiat Med. 2008 Oct;26(8):504-7.
Pattern of tumor recurrence in initially nonmetastatic breast cancer patients: distribution and frequency of metastases at unusual sites
Sanuki-Fujimoto N, Takeda A, Amemiya A, Ofuchi T, Ono M, Yamagami R, Hatayama J, Kunieda E, Shigematsu N.
Cancer. 2008 Aug 15;113(4):677-82.
Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer
Takeda A, Kunieda E, Takeda T, Tanaka M, Sanuki N, Fujii H, Shigematsu N, Kubo A.
Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1057-65.
Gadolinium-Enhanced Three-Dimensional Magnetization-Prepared Rapid Gradient-Echo (3D MP-RAGE) Imaging is Superior to Spin-Echo Imaging in Delineating Brain Metastases
Takeda T, Takeda A, Nagaoka T, Kunieda E, Takemasa K, Watanabe M, Hatou T, Oguro S, Katayama M.
Acta Radiol. 2008; 49:1167-73
Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: Preliminary results for efficacy and toxicity
Takeda A, Takahashi M, Kunieda E, Takeda T, Sanuki N, Koike Y, Atsukawa K, Ohashi T, Saito H, Shigematsu N, Kubo A.
Hepatol Res. 2008 Jan;38(1):60-9
＜2007年以前＞
Differences in the definition of internal target volumes using slow CT alone or in combination with thin-slice CT under breath-holding conditions during the planning of stereotactic radiotherapy for lung cancer
Seki S, Kunieda E, Takeda A, Nagaoka T, Deloar HM, Kawase T, Fukada J, Kawaguchi O, Uematsu M, Kubo A.
Radiother Oncol. 2007 Dec;85(3):443-9.
Experimental stereotactic irradiation of normal rabbit lung: computed tomographic analysis of radiation injury and the histopathological features
Kawase T, Kunieda E, Deloar HM, Seki S, Sugawara A, Tsunoo T, Ogawa EN, Ishizaka A, Kameyama K, Takeda A, Kubo A.
Radiat Med. 2007 Nov;25(9):453-61
Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study
Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Niibe Y, Karasawa K, Hayakawa K, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Hara R, Itami J, Yamada K, Araki T.
J Thorac Oncol. 2007 Jul;2(7 Suppl 3):S94-100.
Evaluation of acute intestinal toxicity in relation to the volume of irradiated small bowel in patients treated with concurrent weekly gemcitabine and radiotherapy for locally advanced pancreatic cancer
Ito Y, Okusaka T, Kagami Y, Ueno H, Ikeda M, Sumi M, Imai A, Fujimoto N, Ikeda H.
Anticancer Res. 2006 Sep-Oct;26(5B):3755-9.
Rotational and translational reproducibility of newly developed Leksell frame-based relocatable fixation system
Kunieda E, Deloar HM, Kitamura M, Kawaguchi O, Shiba H, Takeda A, Kawase T, Seki S, Shigematsu N, Kubo A.
Radiat Med. 2006 Aug;24(7):503-10.
肝細胞癌に対する体幹部定位放射線治療の役割
武田篤也，佐貫直子，岩渕省吾，高塚健太郎，中崎晴弘
胆と膵 2007; 28: 727-733
Radiation therapy after breast-conserving surgery
Shigematsu N, Takeda A, Sanuki N, Fukada J, Uno T, Ito H, Kawaguchi O, Kunieda E, Kubo A.
Radiat Med. 2006 Jun;24(5):388-404. Review.
治療計画装置を用いた乳癌術後照射法について（2）
武田篤也，茂松直之
臨床放射線 2006; 51(1): 196-200
乳房切除後放射線治療の有用性の検討
大渕徹，雨宮厚，武田篤也
乳癌の臨床 2006; 21(5): 443-449
Pro-gastrin-releasing peptide as a factor predicting the incidence of brain metastasis in patients with small cell lung carcinoma with limited disease receiving prophylactic cranial irradiation
Yonemori K, Sumi M, Fujimoto N, Ito Y, Imai A, Kagami Y, Ikeda H.
Cancer. 2005 Aug 15;104(4):811-6.
Benefits of axillary radiotherapy unclear in women with early stage breast cancer undergoing conservative breast surgery without axillary dissection
Sanuki-Fujimoto N.
Cancer Treat Rev. 2005 Oct;31(6):496-500.
Successful pregnancy and normal delivery after whole craniospinal irradiation in two patients
Naoyuki Shigematsu, H. Shinmoto, N Ito, Etsuo Kunieda, Atsuya Takeda, Toshio Ohashi,, Osamu Kawaguchi, T Kawata, H Ito, S Kuribayashi , Atsushi K.
Anticancer Res. 2005 Sep-Oct;25(5):3481-7.
Differences in pulmonary function before vs. 1 year after hypofractionated stereotactic radiotherapy for small peripheral lung tumors
Ohashi T, Takeda A, Shigematsu N, Kunieda E, Ishizaka A, Fukada J, Deloar HM, Kawaguchi O, Takeda T, Takemasa K, Isobe K, Kubo A.
Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1003-8.
Treatment of breast carcinoma in patients with clinically negative axillary lymph nodes using radiotherapy versus axillary dissection
Fujimoto N, Amemiya A, Kondo M, Takeda A, Shigematsu N.
Cancer. 2004 Nov 15;101(10):2155-63.
Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study
Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K, Yamashita T, Niibe Y, Karasawa K, Hayakawa K, Takai Y, Kimura T, Hirokawa Y, Takeda A, Ouchi A, Hareyama M, Kokubo M, Hara R, Itami J, Yamada K.
Cancer. 2004 Oct 1;101(7):1623-31.
Radiation injury after hypofractionated stereotactic radiotherapy for peripheral small lung tumors: serial changes on CT
Takeda T, Takeda A, Kunieda E, Ishizaka A, Takemasa K, Shimada K, Yamamoto S, Shigematsu N, Kawaguchi O, Fukada J, Ohashi T, Kuribayashi S, Kubo A.
AJR Am J Roentgenol. 2004 May;182(5):1123-8.
Evaluation of novel modified tangential irradiation technique for breast cancer patients using dose-volume histograms
Takeda A, Shigematsu N, Ikeda T, Kawaguchi O, Kutsuki S, Ishibashi R, Kunieda E, Takeda T, Takemasa K, Ito H, Uno T, Jinno H, Kubo A.
Int J.Radiation Oncology Biol.Phys.2004.03; 58(4): 1280-1288
Measurement of beam-axis displacement from the isocenter during three-dimensional conformal radiosurgery with a micro-multileaf collimator
Etsuo Kunieda, Osamu Kawaguchi, Hidetoshi Saitoh, Tatsuya Fujisaki, Atsuya Takeda, Takatsugu Kawase, Hossain M. Delor, Naoyuki Shigematsu, Atsushi Kubo
Radiotherapy and Oncology Volume 70, Issue 1, January 2004, Pages 45-48
Intra-arterial CT-angiography for cerebral arteriovenous malformation--initial experiences for treatment planning of radiosurgery
Kunieda E, Kawaguchi O, Onozuka S, Momoshima S, Takeda A, Shigematsu N, Hashimoto S, Ohira T, Kubo A.
Int J Radiat Oncol Biol Phys. 2002 Nov 15;54(4):1121-33.
Cell killing and mutation induction by heavy ion beams
Shigematsu N, Ihara N, Kawata T, Kawaguchi O, Takeda A, Ishibashi R, Kutsuki S, Kubo A, Kanai T, Furusawa Y, Isobe K, Uno T, Ito H.
Int J Mol Med. 2001; 7(5): 509-13 May
